2022-RA-1371-ESGO Multiple-agent chemotherapy as first-line treatment for low risk gestational neoplasm: is it time or not? | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Trophoblastic diseases

2022-RA-1371-ESGO Multiple-agent chemotherapy as first-line treatment for low risk gestational neoplasm: is it time or not?

Free

Online download statistics by month:

Online download statistics by month: October 2022 to April 2024

	Abstract	Full	Pdf
Oct 2022	4	0	1
Nov 2022	34	0	3
Dec 2022	44	0	15
Jan 2023	21	0	4
Feb 2023	74	0	6
Mar 2023	28	0	3
Apr 2023	9	0	2
May 2023	20	0	3
Jun 2023	13	0	5
Jul 2023	6	0	4
Aug 2023	10	0	5
Sep 2023	10	0	2
Oct 2023	15	0	2
Nov 2023	7	0	3
Dec 2023	25	0	4
Jan 2024	8	0	3
Feb 2024	4	0	1
Mar 2024	18	0	6
Apr 2024	6	0	0
Total	356	0	72